+1,900.5%
THC vs AVAV
+358.8%
+1,541.7%
-71.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | AVAV | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.4% | -2.7% | +3.2% | +1.0% |
| 7D | +8.8% | 0.0% | +8.9% | +8.3% |
| 30D | +10.0% | -9.9% | +20.0% | +11.4% |
| 3M | +11.7% | -34.7% | +46.4% | +19.7% |
| 6M | +52.5% | -26.6% | +79.1% | +55.5% |
| YTD | +46.1% | -48.9% | +95.0% | +55.5% |
| 1Y | +49.1% | -63.0% | +112.1% | +70.8% |
| 3Y | +439.6% | +1.6% | +438.1% | +338.2% |
| 5Y | +263.2% | +34.5% | +228.7% | +156.4% |
| 10Y | +1,900.5% | +359.3% | +1,541.2% | +982.8% |
| All | +1,900.5% | +358.8% | +1,541.7% | +982.8% |
Cumulative growth
Daily Returns
Daily percentage return beside AVAV.
Daily Out/Under-Performance
Portfolio return minus AVAV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AVAV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded AVAV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling